![](/img/cover-not-exists.png)
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
Pedrosa, Marcos, Seyedkazemi, Star, Francque, Sven, Sanyal, Arun, Rinella, Mary, Charlton, Michael, Loomba, Rohit, Ratziu, Vlad, Kochuparampil, Jossy, Fischer, Laurent, Vaidyanathan, Sujata, Anstee, QLanguage:
english
Journal:
Contemporary Clinical Trials
DOI:
10.1016/j.cct.2019.105889
Date:
November, 2019
File:
PDF, 2.84 MB
english, 2019